Veracyte Ownership | Who Owns Veracyte?

Overview Forecast RevenueFinancials Chart Transcripts

Veracyte Ownership Summary

Veracyte is owned by 105.97% institutional investors, 0.79% insiders. Blackrock is the largest institutional shareholder, holding 10.42% of VCYT shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 3.87% of its assets in Veracyte shares.

VCYT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Veracyte	105.97%	0.79%	-6.76%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	7.79M	10.42%	$168.88M
Vanguard group	7.50M	10.03%	$162.46M
Wellington management group llp	6.88M	9.20%	$149.01M
Ark investment management	6.81M	9.11%	$147.56M
Dimensional fund advisors lp	3.46M	4.63%	$75.01M
Sumitomo mitsui trust	3.18M	4.26%	$68.95M
Nikko asset management americas	3.18M	4.26%	$68.91M
Champlain investment partners	3.17M	4.24%	$68.64M
Artisan partners limited partnership	3.06M	4.10%	$66.39M
Arrowmark colorado	3.00M	4.01%	$64.96M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Perkins capital management	98.83K	2.02%	$2.14M
Silverarc capital management	282.25K	1.44%	$6.12M
Casdin capital	857.90K	1.42%	$18.59M
Ark investment management	6.81M	1.31%	$147.56M
Efg asset management (north america)	243.88K	0.92%	$5.28M
Virtus investment advisers	49.81K	0.91%	$1.08M
Oberweis asset management inc/	654.10K	0.87%	$14.17M
Granite investment partners	934.99K	0.84%	$20.26M
Nikko asset management americas	3.18M	0.80%	$68.91M
Arrowmark colorado	3.00M	0.77%	$64.96M

Top Buyers

Holder	Shares	% Assets	Change
Exoduspoint capital management, lp	798.64K	0.12%	650.65K
Blackrock	7.79M	0.00%	581.69K
William blair investment management	1.24M	0.07%	500.02K
Champlain investment partners	3.17M	0.42%	470.07K
Aegon asset management uk	759.25K	0.23%	358.00K

Top Sellers

Holder	Shares	% Assets	Change
State street	2.91M	0.00%	-1.42M
Fiera capital	-	-	-625.54K
Point72 asset management	-	-	-566.63K
Wellington management group llp	6.88M	0.03%	-491.28K
Mirae asset global investments	2.28K	0.00%	-463.71K

New Positions

Holder	Shares	% Assets	Change	Value
Mirae asset global etfs	239.57K	0.01%	239.57K	$5.19M
Bridgeway capital management	199.40K	0.10%	199.40K	$4.32M
Norges bank	156.40K	0.00%	156.40K	$3.39M
Cinctive capital management lp	104.67K	0.11%	104.67K	$2.27M
Corebridge financial	41.34K	0.00%	41.34K	$895.88K

Sold Out

Holder	Change
Tfc financial management	-1.00
Opal wealth advisors	-13.00
First command advisory services	-20.00
Covestor	-22.00
Park place capital	-24.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	292	22.18%	81,612,672	-0.60%	105	0.88%	162	38.46%	88	7.32%
Jun 30, 2024	239	-2.05%	82,106,462	0.48%	109	0.92%	117	-21.48%	82	24.24%
Mar 31, 2024	244	-3.17%	81,711,223	5.83%	109	0.98%	149	29.57%	66	-37.14%
Dec 31, 2023	252	6.33%	77,206,775	1.07%	105	0.96%	115	-8.73%	105	36.36%
Sep 30, 2023	237	2.60%	76,389,899	-0.89%	104	0.93%	126	6.78%	77	-3.75%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Disruptive Innovation Full Composite	2.97M	3.87%	-986.73K
Vanguard Explorer Inv	2.80M	3.65%	-1.02M
ARK Innovation ETF	2.81M	3.63%	-20.77K
Vanguard Total Stock Mkt Idx Inv	2.45M	3.16%	-13.70K
iShares Russell 2000 ETF	2.13M	2.75%	-4.45K
Vanguard Small Cap Index	1.92M	2.48%	3.75K
Nikko AM ARK Disruptive Innovation A USD	1.92M	2.48%	-28.58K
ARK Genomic Revolution	1.72M	2.24%	-234.64K
Champlain Small Company Fund, LLC	1.51M	1.94%	-297.59K
ARK Genomic Revolution ETF	1.49M	1.93%	4.59K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 13, 2024	Stapley Marc	Chief Executive Officer	Sell	$17.66K
Dec 13, 2024	Stapley Marc	Chief Executive Officer	Sell	$225.08K
Dec 04, 2024	Febbo Phillip G.	Chief Scientific & Med Officer	Sell	$173.45K
Dec 04, 2024	McGuire Annie	SVP, General Counsel	Sell	$823.18K
Dec 03, 2024	Leite John	Chief Commercial Officer-CLIA	Sell	$45.41K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	11
2024 Q3	-	21
2024 Q2	-	5
2024 Q1	-	1
2023 Q4	-	-

VCYT Ownership FAQ

Who Owns Veracyte?

Veracyte shareholders are primarily institutional investors at 105.97%, followed by 0.79% insiders and -6.76% retail investors. The average institutional ownership in Veracyte's industry, Biotech Stocks , is 47.04%, which Veracyte exceeds.

Who owns the most shares of Veracyte?

Veracyte’s largest shareholders are Blackrock (7.79M shares, 10.42%), Vanguard group (7.5M shares, 10.03%), and Wellington management group llp (6.88M shares, 9.20%). Together, they hold 29.65% of Veracyte’s total shares outstanding.

Does Blackrock own Veracyte?

Yes, BlackRock owns 10.42% of Veracyte, totaling 7.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 168.88M$. In the last quarter, BlackRock increased its holdings by 581.69K shares, a 8.07% change.

Who is Veracyte’s biggest shareholder by percentage of total assets invested?

Perkins capital management is Veracyte’s biggest shareholder by percentage of total assets invested, with 2.02% of its assets in 98.83K Veracyte shares, valued at 2.14M$.

Who is the top mutual fund holder of Veracyte shares?

ARK Disruptive Innovation Full Composite is the top mutual fund holder of Veracyte shares, with 3.87% of its total shares outstanding invested in 2.97M Veracyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools